Letter to the Editor in Response to Paper "BRCA1 Promoter Methylation in Triple-negative Breast Cancer……" by K Daster Et Al

Nikolaienko O, Eikesdal H, Ognedal E, Gilje B, Lundgren S, Blix E . Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome Med. 2023; 15(1):104. PMC: 10698991. DOI: 10.1186/s13073-023-01262-8. View

Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reutersward C, Hakkinen J . Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat Med. 2019; 25(10):1526-1533. PMC: 6859071. DOI: 10.1038/s41591-019-0582-4. View

Tutt A, Tovey H, Chon U Cheang M, Kernaghan S, Kilburn L, Gazinska P . Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nat Med. 2018; 24(5):628-637. PMC: 6372067. DOI: 10.1038/s41591-018-0009-7. View